Table: Towa Pharmaceutical -2025/26 group results

TOWA PHARMACEUTICAL

14/05/2026 07:41

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          273.71          259.59         304.00        145.70   
               (+5.4 pct)      (+13.9 pct)    (+11.1 pct)  (+11.7 pct) 
  Operating       23.10           23.24          32.00         12.70   
               (-0.6 pct)      (+31.7 pct)    (+38.5 pct)  (+21.6 pct) 
  Recurring       28.08           26.15          30.00         11.70   
               (+7.4 pct)      (+6.8 pct)     (+6.8 pct)    (-2.3 pct) 
  Net
  Net              5.25           18.99          21.50          8.10   
               (-72.3 pct)     (+17.4 pct)   (+309.5 pct)   (-1.4 pct) 
  EPS          106.66 yen      385.71 yen     436.75 yen    164.54 yen 
  Ann Div       80.00 yen       70.00 yen      85.00 yen               
  -Q2 Div       40.00 yen       30.00 yen      40.00 yen               
  -Q4 Div       40.00 yen       40.00 yen      45.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T